MENU

LSB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

LakeShore Biopharma (LSB) Ownership - Who owns LakeShore Biopharma?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

51.96M

P/E Ratio

N/A

Total Cash

49.47M

Projected Growth

N/A

Total Debt

368.59M

Revenue

672.27M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

2.59

Total Debt/Equity

N/A

Revenue/Share

5.89 USD as % of share price

Fundamentals

LSB

Capitalization

52M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

49.5M

Total Cash/Share

2.59

Total Debt

369M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

5.89%

Revenue

672M

ROE

N/A

Book Value

603M

P/B Ratio

0.63

Cash Flow

N/A

Earnings

-20.6

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

26K

Current Ratio

1.17

Current Revenue Per Employee

125250.27

Dividends Per Share - Security

N/A

EBITDA

-220.1M

Float

N/A

Float - Current

N/A

Gross Income Margin

81.92

Revenue To Assets

-15.66

Shares Held By Institutions

1.72M

Shares Outstanding - Current

19.1M

Total Liabilities

830M

Total Volume MTD

N/A

Value

1

Gain YTD

-21.301

View a ticker or compare two or three

VS

VS

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details